题名

中醫治療肺癌化療後氧氣供氧量減輕案例報告

并列篇名

Chinese Medicine Treatment Reduced the Amount of Oxygen Supply after Lung Cancer Chemotherapy-A Case Report

DOI

10.7102/JTCIM.201312_11(2).0004

作者

林琬羚(Wan-Ling Lin)；蔡金川(Chin-Chuan Tsai)

关键词

肺癌 ； 化學治療 ； 生脈散 ； lung cancer ； chemotherapy ； Shen-Mai San

期刊名称

中醫內科醫學雜誌

卷期/出版年月

11卷2期（2013 / 12 / 01）

页次

27 - 37

内容语文

繁體中文
中文摘要

肺癌為台灣十大癌症死因之首，肺癌病人在選擇治療的方式之中，由於疾病嚴重程度或屬性，選擇化學治療者相較手術、放射線治療、免疫治療或是緩和照護所佔的比率較多。化學治療雖然可以有效的遏止疾病的發展，但依所使用的治療製劑，有時會導致令人不舒服的副作用。此篇文章報告一例患者在接受肺癌化學治療後衍生肺部積水、氧氣需求不足的情況下，接受中藥生脈散加減方治療後，症狀改善並於狀況穩定下出院。
英文摘要

Lung cancer is the first lead cause of cancer death in Taiwan in 2012. Most patients with lung cancer choose chemotherapy as treatment other than surgery, radiation therapy, immune therapy or palliative therapy according to their stage of disease. Chemotherapy is an effective way to stop the progression of lung cancer. However, it brings some side effects. This study reports complementary Chinese Medicine treatment was applied for a patient with lung cancer who received Chemotherapy and pleura effusion occurred. The oxygen demand was decreasing under the complementary Chinese Medicine treatment. The patient then discharged under a stable condition.
主题分类 醫藥衛生 > 中醫藥學
参考文献
  1. Micromedex 資料庫.
  2. Azzoli, Christopher G.,Baker, Sherman, Jr,Temin, Sarah,Pao, William,Aliff, Timothy,Brahmer, Julie,Johnson, David H.,Laskin, Janessa L.,Masters, Gregory,Milton, Daniel,Nordquist, Luke,Pfister, David G.,Piantadosi, Steven,Schiller, Joan H.,Smith, Reily,Smith, Thomas J.,Strawn, John R.,Trent, David,Giaccone, Giuseppe(2009).American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.JCO,27(36),6251-6266.
  3. Baggstrom, MQ,Stinchcombe, TE,Fried, DB(2007).Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis.J Thorac Oncol.,2,845-853.
  4. Ettinger, DS,Akerley, W,Bepler, G(2010).Non-small cell lung cancer.J Natl Compr Canc Netw.,8,740-801.
  5. Gupta, D,Lis, CG,Grutsch, JF(2007).The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer.J Pain Symptom Manage,34,40-47.
  6. Lee, IY,Lee, CC,Chang, CK,Chien, CH,Lin, MT(2005).Sheng mai san, a Chinese herbal medicine, protects against renal ischaemic injury during heat stroke in the rat.Clin Exp Pharmacol Physiol,32,742-748.
  7. Liu, P,Cao, Y,Qiao, X(2000).Clinical study on shenmai injection in promoting postoperative recovery in patients of breast cancer.Zhongguo Zhong Xi Yi Jie He Za Zhi,20,328-329.
  8. Rajeswaran, A,Trojan, A,Burnand, B(2008).Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: A systematic review of randomized controlled trials.Lung Cancer,59,1-11.
  9. Tsai, Rong-Chi,Yang, Rong-Chi,Wu, Hsiao-Ting,Pang, Jong-Hwei S.,Huang, Sheng-Teng(2011).Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells.Cancer Lett,310(2),198-206.
  10. Xu, N,Qiu, C,Wang, W,Wang, Y,Chai, C,Yan, Y,Zhu, D(2011).HPLC/MS/MS for quantification of two types of neurotransmitters in rat brain and application: myocardial ischemia and protection of Sheng-Mai-San.J Pharm Biomed Anal,55,101-108.
  11. 張志勉、高海青(1997)。生脈注射液治療急性左心衰竭30 例。華西藥學雜誌，12(3)，201-204。
  12. 許堯欽、陳榮洲、林茂村(2003)。生脈散對正常人平臥態血壓、心率與左心室功能作用的研究。中醫藥雜誌，14(1)，33-45。
  13. 萬雪原、王淑芳(2007)。生脈散對充血性心力衰竭患者生活質量的影響。中華中醫藥學刊，25(10)，2193-2194。
  14. 衛生福利部國民健康署：http://www.hpa.gov.tw/BHPNet/Web/Stat/StatisticsShow.aspx?No=201305060001
  15. 衛生福利部統計處：http://www.mohw.gov.tw/cht/DOS/Statistic.aspx?f_list_no=312&fod_list_no=2746
print cancel